Covalon Technologies Inc. Announces Completed Acquisition Of Perfusion Therapeutics’ Gene Therapy Technology

October 24, 2006 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

MISSISSAUGA, ONTARIO -- (MARKET WIRE) -- October 24, 2006 -- Covalon Technologies Ltd. ("Covalon")(TSX VENTURE: COV) today announced that it has completed acquisition of Perfusion Therapeutics' gene therapy technology.

Twitter
LinkedIn
Facebook
Email
Print

Mergers & acquisitions